Phase I Study of CS-7017 and Bexarotene
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Clinical Trial of ARQ 761 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
BKM120 in Cancers With PIK3CA Activating Mutations
- Status
- WITHDRAWN
- Phase
- PHASE2
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase Ib Study of Gemcitabine Plus Cisplatin or Carboplatin Plus Dovitinib in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas
- Status
- WITHDRAWN
- Phase
- PHASE1
Dose Escalation Study of Pazopanib Plus TH-302
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of BKM120 and Everolimus in Advanced Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Study of Safety and Pharmacokinetics of MK-8242 in Participants With Advanced Solid Tumors (P07650)
- Status
- TERMINATED
- Phase
- PHASE1
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of DKN-01 in Multiple Myeloma or Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Tabectedin to Treat Children and Adolescents With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of MM-121 in Combination With Multiple Anticancer Therapies in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Assessment of Quality of Life in Patients With Symptomatic Chemotherapy-induced Anaemia
- Status
- COMPLETED
- Phase
- N/A
Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
- Status
- COMPLETED
- Phase
- PHASE1
Phase 1 Study of Pazopanib With GSK1120212 in Advanced Solid Tumors, Enriched With Patients With Differentiated Thyroid Cancer, Soft-tissue Sarcoma, and Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE1
GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1
Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1)
- Status
- COMPLETED
- Phase
- PHASE1